dandelion leaf and antioxidants

With no further treatment, the 1996 ten-month follow-up data dandelion (n=92) from a high pollen period in Oregon, leaf Washington and Idaho and together showed a greater reduction in the active group antioxidants (n=43) than the placebo group (n=49) on the primary endpoint, defined as a combination of symptom and rescue medication scores.8 Patients gave blood serum samples prior to the dandelion treatment in 1995 and one year later in 1996. They were immunoassayed for specific IgE leaf antibodies using and a chemi-luminescent technique. Statistician Bradley Rosebrook ran T-Tests comparing average baseline IgE levels to one-year. For the seasonal allergens reported, the active group (n=27) had on average a greater reduction in IgE than the placebo group (n=34) for 13 out of 16 allergens.8

“The high CD4/CD8 ratio and suppressed NK cell activity were improved by methyl-B12 treatment.” The Japanese researchers state: antioxidants “We conclude that vitamin B12 acts as an immunomodulator for cellular immunity.”11 B12 was used successfully in the treatment of IgE-mediated skin disorders. The German researchers dandelion conclude that B12 (cobalamin) when applied leaf to the skin one or more times per day exhibited “...excellent results in topical treatment of skin disorders and in particular of inflammatory and hyperproliferative skin ailments and/or and and antioxidants cutaneous manifestations of illness which are immunologic dandelion in origin, e.g. psoriasis, leaf and and atopic dermatitis, contact dermatitis, antioxidants and other eczematous dermatitises...”12 dandelion Click here for Allergy medication online.

All leaf of the active B12 group reporting showed reduction in severity of symptoms ranging from 31% to 70%, while the placebo and controls reported either no change or a worsening of symptoms. Wilcoxon-Rank of .002 for the end-points of sneezing, nasal congestion antioxidants and runny nose; and dandelion p = .005 for IgE reductions. In 1992, leaf the and above antioxidants mentioned data from 1988 on were presented by Dr. O''Connor to the FDA. The FDA panel acknowledged dandelion and leaf the safety of the treatment. The panel seemed to be in agreement that the statistics indicated a significant reduction in IgE and that a quantitative drop in and symptoms was demonstrated. In 1992, antioxidants Belen Anibarro, MD, studied five children with asthma with metabisulfite intolerance confirmed by oral challenge testing. The test was repeated after premedication with 1.5 mg of oral cyanocobalamin. dandelion In four of the five patients treated, leaf bronchospasm and did not develop in the antioxidants second metabisulfite challenge.6